St. Jude Medical, Inc.

Abbott aspires to be a leader in development of "future-ready" cardiac rhythm management (CRM) devices that do not need to be frequently replaced or explanted. Late last year, Medtech Insight talke

Abbott is trying to address heart failure before the patient reaches the hospital. Since it acquired St. Jude Medical in 2017, Abbott has been one of the leading providers of devices that manages a

Don’t mistake a recent drop in False Claims Act (FCA) recoveries for lack of interest in pursuing medtech companies who flout the law, a group of attorneys cautioned at a 10 December conference hosted

Demand and supply of certain types of medtech, industrial operations, supply chains and distribution systems were all impacted, to a greater or lesser extent, by COVID-19 in 2020. So were product deve